Culture Reimagined: How Pharmaceutical Firms Can Use Data and AI with Confidence

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance. Findings from AspenTech® and Longitude’s recent market survey revealed that digital culture and technology adoption provide a competitive edge – but adoption is slow.
 

This report will cover key topics such as:

  • How companies are effectively utilizing data throughout the entire manufacturing process network
  • Barriers companies are facing using artificial intelligence and machine learning technology to derive value from data
  • Impact of the COVID-19 pandemic across organizations, from R&D and vaccine manufacturing capacity to security of supply
  • The four key steps to adaptability, resilience and lasting success

Learn how Pharmaceutical and Biotech companies are responding to unprecedented market volatility, increasing complexity of production and potential risk factors across the value chain.

Culture Reimagined: How Pharmaceutical Firms Can Use Data and AI with Confidence

Why we collect this data:

AspenTechは、当社の事業、可能な限り最善の製品やカスタマーサービスのご提供、そして全体的なユーザエクスペリエンスに関わるさまざまな理由でお客様の個人データを収集および処理する場合があります。当社はお客様の個人データを使用して適宜、アンケートや調査の管理、契約サービスの正確な提供、イベントへの登録、お客様の好みの理解、および不正または不正な活動の検出と防止を行う場合があります。個人データの収集と処理の詳細については、こちらからAspenTechのプライバシーおよびセキュリティポリシーを参照してください。

Culture Reimagined: How Pharmaceutical Firms Can Use Data and AI with Confidence

Hello . If this is not you

Thank you for downloading this resource

If your download did not begin click here